Company: ZLAB
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0001628280-25-018384
Chunk: 63

Company: Zai Lab Ltd
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 63
---
 Awards . Actual amounts earned by each of the named executive officers under our annual bonus program for 2024 are disclosed above in the 2024 Summary Compensation Table .

(3) Each RSU represents a contingent right to receive one ADS, and the stock options are exercisable for ADSs. As a result, the number of shares and exercise price in these columns are represented in terms of ADSs. Each ADS represents ten ordinary shares. RSU and option awards vest in equal annual installments over four years, beginning on the first anniversary of the grant date, subject to the executive remaining in continuous service with us on the vesting date. Option awards have a maximum term of ten years from the grant date.

(4) Amounts reflect the aggregate grant date fair value of restricted share unit awards and stock options granted during 2024, computed in accordance with ASC Topic 718. The underlying valuation assumptions for equity awards granted during 2024 are further discussed in Note 15 in our 2024 Annual Report on Form 10-K.

(5) The RSUs reflected in this row represent the second tranche of the CEO’s annual RSU award for 2024, which was granted in two tranches in 2024.

Each of our named executive officers has entered into an employment agreement that governs the terms and conditions of their employment relationship with us, including the terms and conditions with respect to their compensation and benefits. Among other items, the employment agreements set out the annual bonus targets, as a percentage of base salary, for each of our named executive officers. Please see CD&A – Annual Incentive Awards above for the 2024 bonus targets applicable to our named executive officers.

#### Outstanding Equity Awards at December 31, 2024
The following table provides information on the outstanding stock options, restricted share units, and performance share units, in each case held as of December 31, 2024 by our named executive officers:

<div align='center'>-48-</div>

| Name               |     |            | Grant Date |     |            |     |         |     | Option Awards   
 Number of       
 securities      
 underlying      
 unexercised     
 options         
 (#)             
 exercisable (1) |         |     |         |     | Number of            
 securities           
 underlying           
 unexercised          
 options              
 (#)                  
 unexercisable (1)(2) |         |     |   |        |     | Option   
 exercise 
 price    
 ($)      |        |     |            |